Syndax Pharmaceuticals Inc (SNDX) Stock Price & News

SNDX:NASDAQ

Syndax Pharmaceuticals Inc

$13.40

-1.25%

(-0.17) 1D

$13.66

+1.94% (+0.26)

After hours

Closed: Oct 23, 4:00:00 PM GMT-4 · USD

All symbols

	Symbol	Price	Change	% Change

Generating top insights for SNDX...

Open

$13.60

High

$13.61

Low

$13.20

Mkt. cap

1.20B

Avg. vol.

2.26M

Volume

4.25M

52-wk high

$25.59

52-wk low

$12.80

EPS

-$2.52

Beta

0.43

Shares outstanding

89.30M

No. of employees

298

Open

$13.60

High

$13.61

Low

$13.20

Mkt. cap

1.20B

Avg. vol.

2.26M

Volume

4.25M

52-wk high

$25.59

52-wk low

$12.80

EPS

-$2.52

Beta

0.43

Shares outstanding

89.30M

No. of employees

298

Related stocks

Intellia Therapeutics Inc

$11.21

+0.45%

ARQT

Arcutis Biotherapeutics Inc

$31.20

-3.11%

KLRA

Kailera Therapeutics Inc

$12.85

-3.17%

News stories

From web sources and news partners

Cryptonews.net

10 minutes ago

This S&P 500 crash signal just made a major positive U-turn

Bloomberg.com

5 hours ago

Zero-Day Option Traders Are Betting Against Big S&P 500 Swings

Yahoo Finance

4 hours ago

Dow: 3 Key Takeaways for Long-Term Investors

Stocktwits

6 hours ago

Apollo’s Torsten Slok Warns AI Has Delivered ‘Zero Financial Payoff’ Outside Tech — 'AI Story Will Be Decided In The S&P 493, Not The Mag 7'

About Syndax Pharmaceuticals Inc

CEO-

Employees298

Founded2005

Headquarters-

SectorBiotechnology

Websitesyndax.com

Analyst	Recommendation	Action	Price target	Projected	Date
Yigal Nochomovitz Citi	Buy	Maintained	$57.00	+325.4%	10/13/2026
Jason Zemansky Bank of America Securities	Buy	Maintained	$23.00	+71.6%	10/13/2026
Etzer Darout Barclays	Buy	Maintained	$37.00	+176.1%	10/13/2026
Andres Y. Maldonado H.C. Wainwright	Buy	Maintained	$38.00	+183.6%	10/12/2026
David Dai UBS	Buy	Reiterated	$33.00	+146.3%	08/21/2026
Stephen Willey Stifel Nicolaus	Buy	Maintained	$40.00	+198.5%	08/14/2026
Anupam Rama J.P. Morgan	Buy	Maintained	$40.00	+198.5%	08/11/2026
Phil Nadeau TD Cowen	Buy	Maintained	-	-	08/04/2026
Bradley Canino Guggenheim	Buy	Maintained	$31.00	+131.3%	07/14/2026
Corinne Johnson Goldman Sachs	Buy	Maintained	$34.00	+153.7%	07/14/2026
Faisal Khurshid Jefferies	Buy	Maintained	$37.00	+176.1%	05/01/2026
Unknown Analyst Jefferies	Buy	Maintained	$40.00	+198.5%	03/30/2026
Unknown Analyst Mizuho Securities	Buy	Maintained	$43.00	+220.9%	03/30/2026
Salim Syed Mizuho Securities	Buy	Maintained	$43.00	+220.9%	03/30/2026

All values in USD	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Revenue	45.87M	68.73M	64.86M	72.79M
Cost of goods sold	58.38M	81.35M	61.48M	71.24M
Cost of revenue	58.38M	81.35M	61.48M	71.24M
Research and development expenses	-	-	-	-
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	44.92M	49.93M	37.59M	41.54M
Operating expense	44.92M	49.93M	37.59M	41.54M
Total operating expenses	103.30M	131.28M	99.07M	112.78M
Operating income	-57.43M	-62.55M	-34.20M	-40.00M
Other non operating income	-275.00K	-201.00K	-186.00K	-438.00K
EBT including unusual items	-60.72M	-68.01M	-42.67M	-49.36M
EBT excluding unusual items	-60.72M	-68.01M	-42.67M	-49.36M
Income tax expense	-	-	-	-
Effective tax rate	-	-	-	-
Other operating expenses	-	-	-	-
Net income	-60.72M	-68.01M	-42.67M	-49.36M
Net profit margin	-132.36%	-98.96%	-65.79%	-67.82%
Earnings per share	-0.70	-0.78	-0.48	-0.55
Interest and investment income	5.27M	4.33M	3.56M	3.75M
Interest expense	-8.28M	-9.59M	-11.85M	-12.68M
Net interest expenses	-3.01M	-5.26M	-8.28M	-8.93M
Depreciation and amortization charges	-	-	-	-
EBITDA	-57.42M	-62.54M	-34.20M	-39.99M
Gain or loss from assets sale	-	-	-	-

Ask anything